CD22 (Epratuzumab Biosimilar) 抗体
-
- 抗原 See all CD22 (Epratuzumab Biosimilar) products
- CD22 (Epratuzumab Biosimilar)
-
适用
- 人
-
宿主
-
Humanized
-
克隆类型
- 单克隆
-
标记
- This CD22 (Epratuzumab Biosimilar) antibody is un-conjugated
-
应用范围
- Flow Cytometry (FACS)
- 原理
- Humanized recombinant monoclonal antibody raised against human CD22.
- 特异性
- This antibody was prepared by the humanization of LL2, a murine anti-CD22 IgG2a raised against Raji Burkitt lymphoma cells. Murine sequences comprise 5-10 % of the molecule, with the remainder being human framework sequences, which greatly reduces the potential for immunogenicity.
- 交叉反应
- 人
- 免疫原
- Original antibody is raised against by the humanization of LL2, a murine anti-CD22 IgG2a raised against Raji Burkitt lymphoma cells. Murine sequences comprise 5-10% of the molecule, with the remainder being human framework sequences, which greatly reduces
- 克隆位点
- HL22
- 亚型
- IgG1
-
-
- 应用备注
- Flow cytometry,The optimal working dilution should be determined by the end user.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- In PBS with 0.02 % Proclin 300.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 储存方法
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
- 抗原
- CD22 (Epratuzumab Biosimilar)
- Abstract
- CD22 (Epratuzumab Biosimilar) 产品
- 别名
- SIGLEC-2 antibody, SIGLEC2 antibody, CD22 molecule antibody, CD22 antibody
- 物质类
- Biosimilar
- 背景
- CD22 Molecule
- 基因ID
- 933
-